Plain-English translation of NCT05127278 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at King's College London are developing a new digital screening tool called ENTER to help identify young people who may be in the early stages of psychosis. The tool goes beyond standard questionnaires by asking about life experiences, environmental stressors, and early warning signs. This online approach aims to catch emerging psychosis earlier so young people can get help sooner.
Early detection of psychosis can make a real difference in outcomes for young people. Current screening methods may miss some people at risk, so this study is testing whether a more comprehensive digital tool can identify more young people who need support before their symptoms worsen.
You likely qualify if…
You likely don't qualify if…
You would complete an online screening questionnaire on a website, which would ask about your mental health experiences, life circumstances, and any early warning signs you may have noticed. The study will recruit 3,000 young people through email invitations, flyers, and social media. Your responses would help researchers understand whether this digital tool can effectively identify young people who need mental health support.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United Kingdom
University of Glasgow
Enrollment target
~3,000 participants
Started
April 2022
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
12 Years – 35 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Paolo Fuasr Poli, MD PhD
King's College London
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.